Loading clinical trials...
Loading clinical trials...
A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PTI-808 in Healthy Adult Subjects and in Adults With Cystic Fibrosis
Conditions
Interventions
PTI-808
Placebo
+2 more
Locations
48
United States
Banner University of Arizona Medical Center
Tucson, Arizona, United States
Stanford University Medical Center
Stanford, California, United States
National Jewish Health
Denver, Colorado, United States
Central Florida Pulmonary Group
Altamonte Springs, Florida, United States
Emory Children's Center
Atlanta, Georgia, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Start Date
July 17, 2017
Primary Completion Date
December 23, 2019
Completion Date
December 23, 2019
Last Updated
April 22, 2020
Lead Sponsor
Proteostasis Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions